ArticleRadiation oncology (London, England)2021

Complete response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT mutations and high tumour mutational burden.

Joanne D Stockton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.